Orchid Pharma - Quaterly Results

23 May 2024 Evaluate
The total revenue for the quarter ended March 2024 remained nearly unchanged at Rs. 2171.02 millions.Profit after Tax for the quarter ended March 2024 saw a decline of -49.66% from Rs. 659.31 millions to Rs. 331.87  millions.Operating profit for the quarter ended March 2024 rose to 418.10 millions as compared to 414.17 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 2171.02 2099.01 3.43 8193.68 6658.98 23.05 8193.68 6658.98 23.05
Other Income 128.85 17.29 645.23 303.89 194.30 56.40 303.89 194.30 56.40
PBIDT 418.10 414.17 0.95 1410.70 1030.49 36.90 1410.70 1030.49 36.90
Interest 34.47 74.84 -53.94 163.28 322.26 -49.33 163.28 322.26 -49.33
PBDT 383.63 731.43 -47.55 1247.42 1100.33 13.37 1247.42 1100.33 13.37
Depreciation 84.02 72.12 16.50 332.19 547.87 -39.37 332.19 547.87 -39.37
PBT 299.61 659.31 -54.56 915.23 552.46 65.66 915.23 552.46 65.66
TAX -32.26 0.00 0.00 -32.26 0.00 0.00 -32.26 0.00 0.00
Deferred Tax -32.26 0.00 0.00 -32.26 0.00 0.00 -32.26 0.00 0.00
PAT 331.87 659.31 -49.66 947.49 552.46 71.50 947.49 552.46 71.50
Equity 507.19 408.16 24.26 507.19 408.16 24.26 507.19 408.16 24.26
PBIDTM(%) 19.26 19.73 -2.40 17.22 15.48 11.25 17.22 15.48 11.25

Orchid Pharma Share Price

689.80 -16.95 (-2.40%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×